By Hassan
Malik
Notable
share price increases indicate that a stock has momentum on its side and may
yield favorable investment results. With this in mind, SmallCapPower has
shortlisted six U.S. & Canada-listed small cap stocks that have surged 100%
or more during the past month.
Alter NRG Group (TSX: NRG): Alter NRG
is a Canadian alternate energy solutions company engaged in the treatment of
all types of waste using plasma technology and converting it into useable
energy, such as electricity, syngas, heat, steam or liquid fuels, such as
diesel or ethanol. On April 6, 2015, the company’s share price closed at $4.71.
Closing price for the same date last month was $2.21, accounting for an overall
share price increase of 113%. Alter NRG stock has also outperformed the S&P
TSX by 23.7% during the past year.
Nymox Pharmaceutical Corporation (NASDAQ: NYMX): Nymox
Pharmaceutical is a Canada-based pharmaceutical corporation engaged in the
development of NX-1207, a treatment for benign prostatic hyperplasia (BPH). The
company recently announced that it would begin further analyses of its Phase 3
studies of NX-1207 for prostate enlargement (BPH). On April 6, 2015, the
company’s stock price closed at $1.40. Closing price for the same date last
month was $0.58, accounting for an overall share price change increase of 141%.
Its stock, however, has underperformed the S&P 500 by 86.91% during the
last year.
Voltari Corporation (NASDAQ: VLTC): Voltari delivers
merchandising, digital marketing and advertising solutions, primarily over
smartphones and other mobile devices. The company is currently focused on its
digital media business and is planning to expand its product offerings to add
online and display solutions to its suite of mobile data marketing services. On
April 6, 2015, the company’s share price surged 69% to close at $4.43. Closing
price for the same date last month was $0.90, accounting for a staggering share
price increase of 392%. Its stock price has also outperformed the S&P 500
by 3.97% in the last year.
Recro Pharma Inc. (NASDAQ: REPH): Recro
Pharmais a development stage
pharmaceutical company engaged in developing non-opioid therapeutics for the
treatment of pain, initially for acute pain following surgery. The company’s
main product is an intranasal formulation of Dexmedetomidine (Dex). Its stock,
meanwhile, has momentum behind it considering that it has risen by 174.8% in
the past four weeks, and it is currently trading well above its 20-Day SMA. On
April 6, 2015, its shares closed at $9.30. Closing price for the same date last
month was $3.29, accounting for an overall share price increase of 183%. In
addition, over the last five days, shares of Recro have gained 0.88% and 218.53%
year to date, outperforming the S&P 500 by 17.73% during the past year.
Luxor Industrial Corp. (TSXV: LRL): Luxor develops,
manufactures, and markets wood building components for the construction of
floor and wall systems in residential and light commercial buildings. In the Q1
of 2015, the company reported that sales exceeded $995,000 compared to $383,778
in 2014. On April 6, 2015, the company’ stock closed at $0.19. Closing price
for the same date last month was $0.08, accounting for an overall share price rise
of approximately 138%. In addition, shares of Luxor have gained 5.71% over the
last week and have outperformed the S&P TSX by 264.15% in the last
year.
Entourage Metals Ltd. (TSXV: EMT): Entourage
is an exploration stage company involved in the acquisition and assessment of
mineral properties in Canada. Notably, Entourage Mineral does not have any
producing mineral properties at this time, however its properties include:
Black Raven, October Gold Property and Hemlo Belt Properties. On April 6, 2015,
the company’s stock gained 33% to close at a price of $0.20. Closing price for
the same date last month was $0.08, accounting for an overall share price increase
of 150%. In addition, shares of Entourage have gained 19.23% over the last five
trading days and 138.46% year to date. However, its stock has underperformed
the S&P TSX by 2.52% during the last year.
Disclaimer: This article was posted with
the permission of a third-party contributor and the opinions contained
therein do not necessarily reflect those of SmallCapPower. SmallCapPower
does not endorse any investment advice provided by these third-party
contributors.
Please consult your investment advisor
before making any investment decisions. Ubika Corporation and its
divisions SmallCapPower, Ubika Communication and Ubika Research are not
registered with any financial or securities regulatory authority in
Ontario or Canada, and do not provide nor claims to provide investment advice or
recommendations to any visitor of this site or readers of any content on
this site. – See more at: http://www.smallcappower.com/posts/small-cap-power-disclosure
